SEI Investments’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
SEI Investments's DYN Position: Q3 2026 in Review
SEI Investments increased its Dyne Therapeutics (DYN) stake by 51% in Q3 2026, buying an estimated $517K and bringing the position to 66,563 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2266.
SEI Investments first reported a position in DYN in Q1 2024 and has held it in 6 quarters since. The position peaked at $1.15M in Q4 2025. 109 funds tracked by Wall St. Rank hold DYN as of Q3 2026.
- SEI Investments held 66,563 shares of Dyne Therapeutics worth $1.07M as of Q3 2026.
- SEI Investments bought 22,509 Dyne Therapeutics shares in Q3 2026, an estimated $517K.
- Dyne Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2266 holding.
- SEI Investments first reported a position in Dyne Therapeutics in Q1 2024 and has held it in 6 quarters since.
- SEI Investments's Dyne Therapeutics position peaked at $1.15M in Q4 2025.
- 109 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.
Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.